[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363783-105":59,"doc-detail-363783-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recurrent-primary-hyperparathyroidism-with-ipsilateral-multifocal-papillary-thyroid-carcinoma-of-classical-warthin-like-and-follicular-variants-harboring-distinct-braf-and-nras-mutations-a-rare-case-report","Recurrent primary hyperparathyroidism with ipsilateral multifocal papillary thyroid carcinoma of classical, warthin-like, and follicular variants harboring distinct BRAF and NRAS mutations: a rare case report","","Recurrent primary hyperparathyroidism (PHPT) can arise after parathyroidectomy and poses additional clinical difficulties, especially when accompanied by papillary thyroid carcinoma (PTC). The case describes a 48-year-old Saudi woman with biochemically confirmed PHPT who initially had Hashimoto’s thyroiditis and a parathyroid follicular cell lesion. Six months later, biochemical recurrence led to ultrasound and fine-needle aspiration confirming a suspicious right thyroid nodule, and completion surgery found multifocal PTC with three histological variants bearing distinct BRAFV600E and NRAS G13R mutations, plus ipsilateral parathyroid adenoma/hyperplasia. Molecular profiling supported independent clonal origins. The authors highlight comprehensive thyroid evaluation and individualized surgical planning, emphasizing the role of molecular testing in tumor clonality for complex endocrine neoplasia.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recurrent-primary-hyperparathyroidism-with-ipsilateral-multifocal-papillary-thyroid-carcinoma-of-classical-warthin-like-and-follicular-variants-harboring-distinct-braf-and-nras-mutations-a-rare-case-report/363783/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recurrent-primary-hyperparathyroidism-with-ipsilateral-multifocal-papillary-thyroid-carcinoma-of-classical-warthin-like-and-follicular-variants-harboring-distinct-braf-and-nras-mutations-a-rare-case-report/363783.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How common is the coexistence of primary hyperparathyroidism and papillary thyroid carcinoma?","Question",{"text":112,"@type":113},"The coexistence of PHPT and PTC occurs in about 2–5% of surgical series, with notable variation between institutions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What recurrence criteria and timing define recurrent PHPT in the report?",{"text":117,"@type":113},"Recurrent PHPT is defined as biochemical hyperparathyroidism reappearing more than six months after the initial parathyroidectomy, typically due to incomplete excision, multiglandular disease, or supernumerary glands.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular findings were identified in the multifocal PTC?",{"text":121,"@type":113},"The right thyroidectomy revealed classical, a 1.2 cm Warthin-like variant with BRAFV600E mutation, and a 0.2 cm follicular variant with NRAS G13R mutation, with molecular testing supporting distinct clonal origins.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363783,1790211912,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Maghdi et al. World Journal of Surgical Oncology (2026) 24:274  \n[https://doi.org/10.1186/s12957-026-04409-0](https://doi.org/10.1186/s12957-026-04409-0)  \nWorld Journal of Surgical Oncology  \nCASE REPORT Open Access  \nRecurrent primary hyperparathyroidism with ipsilateral multifocal papillary thyroid carcinoma of classical, warthin-like, and follicular variants harboring distinct BRAFand NRAS mutations: a rare case report  \nShaima Ali Maghdi1, Jobran M. Moshi2,3,4,5, Alanoud Awaji Hakami6, Mutaz Abdulrahman S. Alahdal7,8, Aamir Gazali M. Ishaq9, Ahmed Mohsen Safhi10, Fahd Alaajam2, Ali Baity2, Siddig Ibrahim Abdelwahab4* and Humaid O Al-Shamsi11,12,13,14,15  \nAbstract  \nBackground The coexistence of primary hyperparathyroidism (PHPT) and papillary thyroid carcinoma (PTC) occurs in 2–5% of surgical series. Recurrent PHPT following parathyroidectomy presents additional clinical challenges. While synchronous PHPT and PTC have been documented, the simultaneous occurrence of multifocal PTC exhibiting three distinct histological variants with different oncogenic driver mutations, accompanied by ipsilateral parathyroid pathology, appears not to have been previously reported in the available literature.  \nCase presentation A 48-year-old Saudi female with hypothyroidism underwent left inferior parathyroidectomy and left hemithyroidectomy for biochemically confirmed PHPT. Initial histopathology revealed Hashimoto’s thyroiditis and parathyroid follicular cell lesion. Six months postoperatively, she developed biochemical recurrence (serum calcium 2.77 mmol/L; PTH 21 pg/mL) . Subsequent neck ultrasound demonstrated a suspicious right thyroid nodule (TIRADS 5), confirmed as Bethesda category V on fine-needle aspiration cytology. Completion right thyroidectomy with right inferior parathyroidectomy revealed multifocal PTC comprising classical variant foci, a 1.2 cm Warthin-like variant harboring BRAFV600E mutation, and a 0.2 cm follicular variant with NRAS G13R mutation. Concurrent right inferior parathyroid adenoma/hyperplasia was identified. Molecular testing (Idylla Biocartis platform) confirmed distinct mutational profiles, establishing independent clonal origins.  \nConclusion To our knowledge, after review of the available literature, this appears to be the first reported case of recurrent PHPT with synchronous ipsilateral parathyroid adenoma/hyperplasia and multifocal PTC comprising three histological variants with distinct molecular alterations. This unique presentation underscores the necessity for  \n*Correspondence:  \nSiddig Ibrahim Abdelwahab [siddigroa@yahoo.com](siddigroa@yahoo.com); [sadiqa@jazanu.edu.sa](sadiqa@jazanu.edu.sa)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nMaghdi et al. World Journal of Surgical Oncology (2026) 24:274 Page 2 of 9  \ncomprehensive thyroid evaluat","cbCaiq5MuIyOC66Z","https://ap.wps.com/l/cbCaiq5MuIyOC66Z","pdf",1726045,"English","# Abstract\n## Background\n## Case presentation\n## Conclusion\n# Introduction","[{\"question\":\"How common is the coexistence of primary hyperparathyroidism and papillary thyroid carcinoma?\",\"answer\":\"The coexistence of PHPT and PTC occurs in about 2–5% of surgical series, with notable variation between institutions.\"},{\"question\":\"What recurrence criteria and timing define recurrent PHPT in the report?\",\"answer\":\"Recurrent PHPT is defined as biochemical hyperparathyroidism reappearing more than six months after the initial parathyroidectomy, typically due to incomplete excision, multiglandular disease, or supernumerary glands.\"},{\"question\":\"What molecular findings were identified in the multifocal PTC?\",\"answer\":\"The right thyroidectomy revealed classical, a 1.2 cm Warthin-like variant with BRAFV600E mutation, and a 0.2 cm follicular variant with NRAS G13R mutation, with molecular testing supporting distinct clonal origins.\"}]","Recurrent primary hyperparathyroidism with ipsilateral multifocal papillary thyroid carcinoma of classical, warthin-like, and follicular variants harboring distinct BRAF and NRAS mutations: a rare case report | PDF",1790153131,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c877dbe85ea3d0b3320e4daba0e7d4f.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cacda58820fd611e63cfd2f5ee62af1b.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d994e2092b5e4b9a7e4fa51b3d4c8c6.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6700c39ae3413acca4992fa60a6b026e.webp",980,1306]